LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--Evaluate, a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, is delighted to announce that it has ...
LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--The top 600 biopharma firms added $487 billion in market capitalisation in 2020, according to the Evaluate Vantage Pharma, Biotech & Medtech 2020 in Review ...
Evaluate, a Norstella subsidiary, bought J+D Forecasting, a U.K.-based pharma forecasting solutions company, Wednesday morning. Terms of the deal were not disclosed, but Evaluate heralded J+D ...
The story of Eli Lilly and Novo Nordisk’s GLP-1 dominance is likely to play out again in 2025 as the metabolic medicine rivals continue to smooth over supply issues and rake in dividends from their ...
LONDON – [7 th January 2025] – Evaluate, the leading provider of market insights for the pharmaceutical industry, today released its 2025 Preview report featuring updated forecasts for the biopharma ...
Both companies are now under the Norstella umbrella. Evaluate announced the acquisition of J+D Forecasting, a provider of forecasting solutions focused on the pharmaceutical and life sciences industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback